Evidence map›Paper›PMID 42488336›Full record

ReviewExperimental and therapeutic medicine2026

Research progress of lactylation modification in tumors (Review).

Shi-Chao Fang, Zhi-Zhou Shi

Abstract readReview
In one paragraph

Review in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shi-Chao FangLaboratory of Molecular Neurobiology, Faculty of Medicine, Kunming University of Science and Technology, Kunming, Yunnan 650500, P.R. China.
Zhi-Zhou ShiLaboratory of Molecular Neurobiology, Faculty of Medicine, Kunming University of Science and Technology, Kunming, Yunnan 650500, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactic acid was once thought to be only a metabolic product of glycolysis. An increasing number of studies, however, have reported that lactic acid produced by glycolysis is a multifunctional signaling molecule that not only serves as an essential energy source, signaling molecule and immunomodulatory molecule but also controls metabolism, the immune response and intercellular communication. It has been discovered that lactylation is a posttranslational modification of proteins that regulates and creates an acidic tumor microenvironment, directly regulates gene expression and promotes the recruitment and management of immune signaling molecules, among other processes, to promote tumor survival and progression. The lactylation of histones and non-histone proteins, which is regulated by different mechanisms, is a notable subject of current research on the tumor microenvironment and tumor progression. The present review covered the discovery of lactylation and the research advances on the role of lactylation in metabolism, immunity, metastasis and cell proliferation across different tumors. These findings open up the possibility for in-depth investigation of the role of lactylation in tumors.

Indexed as

cell proliferationimmunitylactylationmetabolismmigration

Identifiers

PMID42488336
PMCPMC13389648

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.